Effect of Mirabegron on Intraocular Pressure in Patients with Glaucoma
Journal Title: Journal of Urological Surgery - Year 2020, Vol 7, Issue 2
Abstract
Objective: Assessment of the effects of mirabegron treatment used for overactive bladder (OAB) symptoms in glaucoma patients on intraocular structures. Materials and Methods: One hundred-twenty six female glaucoma patients, who received mirabegron treatment for OAB symptoms between January 2017 and January 2018, were included in the study. One hundred-twenty female glaucoma patients were chosen as controls. The mean age of the patients in the study and control groups was 46.74 and 44.42, respectively. A daily single dose of 50 mg mirabegron was prescribed for OAB treatment. Intraocular pressure (IOP) was assessed in 4th and 12th weeks in both groups. In the beginning of the treatment period, the mean IOP was 15.20 (±3.20) mmHg in the study group and 15.70 (±4.20) mmHg in controls. Results: The mean IOP in the study group was 15.80 (±3.80) mmHg and 16 (±4.20) mmHg on the 4th and 12th weeks, respectively. The mean IOP controls was 15.60 (±4.80) and 15.80 (±3.20) mmHg on the 4th and 12th weeks, respectively. No significant difference was found on the 4th and 12th weeks of treatment between the groups in terms of intraocular pressure. Conclusion: Mirabegron treatment used for OAB does not affect IOP in patients treated for primary open-angle glaucoma.
Authors and Affiliations
Emine Şeker Ün, Sıtkı Ün
Global Publication Outcomes in Retrograde Intrarenal Surgery and Turkiye’s Effectiveness: A Bibliometric Analysis between 1980 and 2019
Objective: Urinary system stone disease is a very common health problem that affects 2 to 3% of people and causes serious complications when it is not treated. The prevalence of renal stones has been increasing worldwide...
Tamsulosin-induced Hyperprolactinemia in a Patient with Multiple Sclerosis: A Case Report
Drug-induced hyperprolactinemia is one of the most common causes of non-physiologic hyperprolactinemia. In contrary to other anterior pituitary hormones, prolactin is not controlled via hypothalamic-pituitary negative fe...
Parameatal Urethral Cyst: A Case Report
A parameatal urethral cyst is a rare benign congenital anomaly. Approximately 50 patients with parameatal urethral cysts have been reported in the literature. These cysts are usually asymptomatic. They are recognized and...
Bacillus Calmette-Guerin Increases Base Excision Repair in Bladder Cancer Cells
Objective: Most patients with non-muscle-invasive bladder cancer (NMIBC) do not respond to intravesical Bacillus Calmette-Guerin (BCG) immunotherapy and have high risk of NMIBC recurrence and progression. In addition to...
A Rare Variant of Urethral Duplication: Type-3 Bladder and Complete Urethral Duplication
Urethral duplication is a rare congenital anomaly with several anatomical variations. Persistence of duplicated urethra and related sphincter mechanism are mainly the reasons for the symptoms. We here present a 9-month-o...